Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Asiaticoside (50 mg/kg daily) blocks the development of hypoxic pulmonary hypertension (PH)
Nattokinase is a potent fibrinolytic enzyme
and the antioxidant capacity can be determined spectrophotometrically
Silmitasertib sodium salt
InChi: InChI=1S/C26H32N4O8/c31-21(9-13-29-24(34)7-8-25(29)35)27-12-16-38-18-17-37-15-11-22(32)28-20-4-1-19(2-5-20)3-6-23(33)30-14-10-26(30)36/h1-2
ALW-II-41-27 - CAS# 1186206-79-0 Size:Solid 10 mg Asiaticoside (50 mg/kg daily) blocksALW II 41 27 is a Eph receptor tyrosine kinase inhibitor. pharmacologic inhibition of EPHA2 by the small molecule inhibitor ALW II 41 27 decreased both survival and proliferation of erlotinib resistant tumor cells and inhibited tumor growth in vivo. ALW II 41 27 was also effective in decreasing viability of cells with acquired resistance to the third generation EGFR TKI AZD9291. Collectively, these data define a role for EPHA2 in the maintenance of
US$ 154.50
US$ 250.50